covid and glutathione How IV Therapy Helps Combat COVID-19 Lack of glutathione endangers COVID-19

It does not play well with strong actives that drive exfoliation or shift skin pH

stem cell activation (PMID: 20880960) Hair: Stimulated hair follicle stem cells in preclinical research (PMID: 14657002) Human Clinical Data Both peptides lack robust human clinical trial data, though Thymosin Beta-4 (the parent compound of TB-500) has more formal clinical exposure through RegeneRx Biopharmaceuticals' development programs

Rapid Absorption : The nasal mucosa is highly vascularized, allowing for quick absorption of the peptides into the bloodstream, leading to faster onset of action

BPC-157 is not FDA-approved and was nominated for, then removed from, 503B bulk-compounding eligibility in 2024 based on FDA's safety review